Evidence map›Paper›PMID 26247835›Full record

ArticleXenobiotica; the fate of foreign compounds in biological systems2016

Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13.

Tsutomu Shimada, Shigeo Takenaka, Norie Murayama, Valerie M Kramlinger, Joo-Hwan Kim, Donghak Kim, Jiawang Liu, Maryam K Foroozesh, Hiroshi Yamazaki, F Peter Guengerich and 1 more

Open access · greenAbstract read
In one paragraph

Article in Xenobiotica; the fate of foreign compounds in biological systems, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic and Enzymatic Characteristics of CYP2A13 in Relation to Lung Damage.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Article
  6. Cytochrome P450 2A6 and other human P450 enzymes in the oxidation of flavone and flavanone.Xenobiotica; the fate of foreign compounds in biological systems · 2019
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Tsutomu Shimadaa Laboratory of Cellular and Molecular Biology , Graduate School of Life and Environmental Sciences, Osaka Prefecture University , Izumisano , Osaka , Japan .
Shigeo Takenakaa Laboratory of Cellular and Molecular Biology , Graduate School of Life and Environmental Sciences, Osaka Prefecture University , Izumisano , Osaka , Japan .
Norie Murayamab Laboratory of Drug Metabolism and Pharmacokinetics , Showa Pharmaceutical University , Machida , Tokyo , Japan .
Valerie M Kramlingerc Department of Biochemistry and Center in Molecular Toxicology , Vanderbilt University School of Medicine , Nashville , TN , USA .
Joo-Hwan Kimd Department of Biological Sciences , Konkuk University , Seoul , Republic of Korea , and.
Donghak Kimd Department of Biological Sciences , Konkuk University , Seoul , Republic of Korea , and.
Jiawang Liue Department of Chemistry , Xavier University of Louisiana , New Orleans , LA , USA.
Maryam K Foroozeshe Department of Chemistry , Xavier University of Louisiana , New Orleans , LA , USA.
Hiroshi Yamazakib Laboratory of Drug Metabolism and Pharmacokinetics , Showa Pharmaceutical University , Machida , Tokyo , Japan .
F Peter Guengerichc Department of Biochemistry and Center in Molecular Toxicology , Vanderbilt University School of Medicine , Nashville , TN , USA .
Masayuki Komoria Laboratory of Cellular and Molecular Biology , Graduate School of Life and Environmental Sciences, Osaka Prefecture University , Izumisano , Osaka , Japan .
Osaka Prefecture University · JPKonkuk University · KRShowa Pharmaceutical University · JPVanderbilt University · USXavier University of Louisiana · US

Funding

Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
Xavier's RCMI Cancer Research ProgramG12MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI D'AMOUR, GENE, WANG, GUANGDI · 2012 to 2018
$15.7M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
X RAY MODELING OF DOPAMINE AGONISTSS06GM008008 · NIGMS · XAVIER UNIVERSITY OF LOUISIANA · PI GOLOVERDA, GALINA Z. · 1989 to 2007
$9.5M
Metabolism of Carcinogens and Drugs by Human P450sR37CA090426 · NCI · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 2006 to 2015
$3.6M
Metabolism of Carcinogens and Drugs by Human P450sR01CA090426 · NCI · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 2001 to 2005
$1.7M
NCI NIH HHS R01 CA090426NCI NIH HHS R37 CA090426NIEHS NIH HHS P30 ES000267NIEHS NIH HHS T32 ES007028NIGMS NIH HHS S06 GM008008NIGMS NIH HHS S06 GM08008NIMHD NIH HHS G12 MD007595
6 · The paper itself

Abstract

1. The polycyclic hydrocarbons (PAHs), pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene, were found to induce Type I binding spectra with human cytochrome P450 (P450) 2A13 and were converted to various mono- and di-oxygenated products by this enzyme. 2. Pyrene was first oxidized by P450 2A13 to 1-hydroxypyrene which was further oxidized to di-oxygenated products, i.e. 1,8- and 1,6-dihydroxypyrene. Of five other human P450s examined, P450 1B1 catalyzed pyrene oxidation to 1-hydroxypyrene at a similar rate to P450 2A13 but was less efficient in forming dihydroxypyrenes. P450 2A6, a related human P450 enzyme, which did not show any spectral changes with these four PAHs, showed lower activities in oxidation of these compounds than P450 2A13. 3. 1-Nitropyrene and 1-acetylpyrene were also found to be efficiently oxidized by P450 2A13 to several oxygenated products, based on mass spectrometry analysis. 4. Molecular docking analysis supported preferred orientations of pyrene and its derivatives in the active site of P450 2A13, with lower interaction energies (U values) than observed for P450 2A6 and that several amino acid residues (including Ala-301, Asn-297 and Ala-117) play important roles in directing the orientation of these PAHs in the P450 2A13 active site. In addition, Phe-231 and Gly-329 were found to interact with pyrene to orient this compound in the active site of P450 1B1. 5. These results suggest that P450 2A13 is one of the important enzymes that oxidizes these PAH compounds and may determine how these chemicals are detoxicated and bioactivated in humans.

Indexed as

Oxidation-ReductionAnimalsAryl Hydrocarbon HydroxylasesCytochrome P-450 CYP1A1Cytochrome P-450 CYP2A6HumansLepidopteraModels, BiologicalMolecular Docking SimulationPolycyclic CompoundsPyrenes1-hydroxypyrene1-nitropyreneAryl Hydrocarbon HydroxylasesCYP2A13 protein, humanCYP2A6 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP2A6Polycyclic CompoundspyrenePyrenes1-Acetylpyrene1-hydroxypyrene1-nitropyreneoxidationP450 2A13pyrene

Identifiers

PMID26247835
PMCPMC5270756
OpenAlexW1712187248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.